Stem cell transplant reverses early stage multiple sclerosis CHICAGO --- Researchers from Northwestern University's Feinberg School of Medicine appear to have reversed the neurological dysfunction of early-stage multiple sclerosis patients by transplanting their own immune stem cells into their bodies and thereby "resetting" their immune systems.
"This is the first time we have turned the tide on this disease," said principal investigator Richard Burt, M.D. chief of immunotherapy for autoimmune diseases at the Feinberg School. The clinical trial was performed at Northwestern Memorial Hospital where Burt holds the same title.
Posting comments can be beneficial to others and it allows you to express yourself. If you have a statement or question pertaining to this article, this is the place to leave it. Click the link below the article that reads: Post Comments. - Thank You ============================================